IBDIQ
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

IBDIQ Trademark

Serial Number: 98584115 • Registration: 8306168

IBDIQ is a trademark filed by Takeda Pharmaceuticals U.S.A., Inc. on June 4, 2024. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall Street
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

June 4, 2024

Registration Date

June 16, 2026

Published for Opposition

April 15, 2025

Goods & Services

Healthcare provider and medical professional support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve the understanding of healthcare providers and medical professionals about inflammatory bowel disease (IBD) and pharmaceutical treatment thereof

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 16, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 27, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 27, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 18, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 18, 2026 AITU
USE AMENDMENT FILED
Nov 17, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 17, 2025 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 11, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2025 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 10, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 3, 2024 NWOS
NEW APPLICATION ENTERED
Jun 4, 2024 NWAP